What an incredible day at the Neuroendocrine Cancer Patient Conference in Atlanta, with over 100 incredibly engaged guests! We are so grateful to @UGrewalMD, our speakers, patients, caregivers, clinicians, advocates and sponsors for coming together to learn, connect, and support one another. Seeing such a strong turnout reminds us of the power and resilience of this incredible community. A special thank you to our outstanding speakers from Emory, Vanderbilt, and UAB, as well as our generous sponsors, for helping make this event possible. 💚 #neuroendocrinecancer #netcancer #netawareness

Missed our December webinar with @AmanChauhanMD? You can now watch the full December webinar at your convenience. 💻Watch here: ncf.net/events/dec2025 After viewing, please take a moment to complete our short survey—your feedback helps shape future programs and better support our community. ➡️Take the survey: forms.gle/SBWAftnpUWbB1MDJ9 @CarcinoidNETs @NANETS1 #NeuroendocrineCancer #NETCommunity #CancerEducation #PatientSupport #ncfcancer #NeuroendocrineTumor #NETCancer

📢New Read Worth Sharing AARP recently published a moving article by @JamieMetzl about his family’s experience navigating a neuroendocrine cancer diagnosis and the important lessons they learned along the way. Written with honesty and insight, the piece offers both a heartfelt perspective and practical guidance for anyone impacted by cancer. Read the full article here: jamiemetzl.com/wp-content/up… Jamie Metzl’s story reminds us of the power of resilience, informed care, and the support of loved ones in the face of life’s toughest challenges. His writing brings both compassion and clarity to a deeply personal journey that many can relate to. #cancerawareness #cancercare #jamiemetzl #AARP #PatientStories #HopeAndSupport #ncfcancer #NeuroendocrineCancer #NeuroendocrineTumor #NETCancer #NETcancerawareness

💟 "The email that changed everything." After being diagnosed with a neuroendocrine tumor, Dusty felt scared, isolated, and unsure of where to turn. One of the first emails she received from NCF said, “You are not alone. We are here to help.” That message became the start of community, education, and empowerment. Read Dusty’s story: 👉ncf.net/post/the-email-that-… #NeuroendocrineCancer #NETCancer #PatientStory #youarenotalone #ncfcancer #NETcancerawareness #NeuroendocrineTumor

✨Thankful Today and Every Day This Thanksgiving, @NCFCancer extends heartfelt gratitude to the patients, families, caregivers, clinicians, researchers, and advocates who make up our global NET community. Together, you bring strength, connection, and hope — and you remind us that no one facing neuroendocrine cancer walks alone. We invite you to revisit the impact and inspiration of this year’s NET Cancer Day Symposium — a celebration of community, progress, and legacy: ncf.net/post/world-net-cance… This year, we give thanks for: 🤎Patients who persevere with strength and grace 💛Families and caregivers who provide unwavering support 🤎 Clinicians delivering compassionate, specialized care 💛Researchers advancing science and treatment options 🤎Advocates raising awareness and amplifying patient voices 💛A global community united by purpose, empathy, and hope Today, we honor lives, celebrate resilience, and express deep appreciation for every person helping raise awareness and advance our mission. From all of us at NCF — Thank you for your courage, your voice, and your partnership. @CarcinoidNETs @AmanChauhanMD @UGrewalMD @SylvesterCancer @Latinamd #Thanksgiving #NETCancer #NETStrong #NETcancerday #WorldNETCancerDay #Gratitude

New Research Update: Promising Results for Alpha Therapy in NETs October 8, 2025 — Sanofi announced that its investigational treatment AlphaMedix™ (²¹²Pb-DOTAMTATE) met all primary goals in a phase 2 clinical trial, showing meaningful benefits for patients with gastro-pancreatic neuroendocrine tumors (GEP-NETs)—including those who had previously received radiation therapy. The treatment was generally well tolerated, and these findings pave the way for future discussions with regulators toward potential approval. 📰 Read the full press release: sanofi.com/en/media-room/pre… 📺 Learn more about alpha therapy and the evolving PRRT landscape: Watch our recent webinar at ncf.net/events/sep2025 ➡️ Explore additional PRRT resources: ncf.net/prrt